Group One Trading’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-400
| Closed | -$4K | – | 5475 |
|
|
2017
Q2 | $4K | Buy |
+400
| New | +$4K | ﹤0.01% | 4497 |
|
|
2017
Q1 | – | Sell |
-100
| Closed | -$1K | – | 5303 |
|
|
2016
Q4 | $1K | Sell |
100
-6,300
| -98% | -$63K | ﹤0.01% | 4364 |
|
|
2016
Q3 | $66K | Sell |
6,400
-37,200
| -85% | -$405K | ﹤0.01% | 3189 |
|
|
2016
Q2 | $569K | Buy |
+43,600
| New | +$571K | 0.01% | 1643 |
|
|
2016
Q1 | – | Sell |
-2,500
| Closed | -$23K | – | 5305 |
|
|
2015
Q4 | $23K | Sell |
2,500
-21,800
| -90% | -$182K | ﹤0.01% | 3856 |
|
|
2015
Q3 | $169K | Sell |
24,300
-20,800
| -46% | -$178K | ﹤0.01% | 2647 |
|
|
2015
Q2 | $443K | Buy |
45,100
+24,600
| +120% | +$224K | 0.01% | 1885 |
|
|
2015
Q1 | $182K | Sell |
20,500
-8,800
| -30% | -$70.1K | ﹤0.01% | 2446 |
|
|
2014
Q4 | $257K | Sell |
29,300
-16,400
| -36% | -$133K | ﹤0.01% | 2100 |
|
|
2014
Q3 | $315K | Sell |
45,700
-31,500
| -41% | -$189K | ﹤0.01% | 1991 |
|
|
2014
Q2 | $406K | Buy |
77,200
+73,900
| +2,239% | +$360K | 0.01% | 1815 |
|
|
2014
Q1 | $15K | Sell |
3,300
-4,800
| -59% | -$23.2K | ﹤0.01% | 4420 |
|
|
2013
Q4 | $41K | Sell |
8,100
-31,200
| -79% | -$150K | ﹤0.01% | 3783 |
|
|
2013
Q3 | $199K | Sell |
39,300
-2,700
| -6% | -$15K | ﹤0.01% | 2393 |
|
|
2013
Q2 | $208K | Buy |
+42,000
| New | +$200K | 0.01% | 2141 |
|
Group One Trading's SCLN Position: Q4 2017 in Review
Group One Trading sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 300 shares — an estimated $3K sold.
Group One Trading first reported a position in SCLN in Q2 2013 and held it in 5 quarters. The position peaked at $18K in Q1 2014. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.
- Group One Trading reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
- Group One Trading sold 300 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $3K.
- Group One Trading first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
- Group One Trading's Sciclone Pharmaceuticals Inc position peaked at $18K in Q1 2014.
- 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.
Based on Group One Trading's 13F filing for Q4 2017, filed 9 Feb 2018.